Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedA banner announces NIH website transition updates and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.6%

- Check34 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2, with no change to the study record content.SummaryDifference0.1%

- Check41 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry, v3.7.0, is added to the history and the previous revision v3.6.6 is removed from the list, updating the visible revision trail for the study record.SummaryDifference0.1%

- Check83 days agoChange DetectedThe study history now shows a new revision label v3.6.6, replacing the previous v3.6.5, indicating an update to the page's revision record.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.